Activity of sunitinib in extraskeletal myxoid chondrosarcoma.
暂无分享,去创建一个
A. D. Dei Tos | P. Casali | T. Negri | S. Pilotti | R. Maestro | A. Gronchi | C. Morosi | S. Stacchiotti | A. Astolfi | M. Pantaleo | F. Crippa | V. Indio | L. Toffolatti | M. Tazzari | G. Dagrada | C. Colombo | E. Conca | A. Tos
[1] F. Grosso,et al. Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study , 2013, Clinical Sarcoma Research.
[2] P. Casali,et al. Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib , 2012, Clinical Sarcoma Research.
[3] L. Bolund,et al. Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions , 2012, PloS one.
[4] A. Kawai,et al. Extraskeletal myxoid chondrosarcoma: a review of 23 patients treated at a single referral center with long-term follow-up , 2012, Archives of Orthopaedic and Trauma Surgery.
[5] Chris Sander,et al. RNA targets of wild-type and mutant FET family proteins , 2011, Nature Structural &Molecular Biology.
[6] P. Casali,et al. Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] H. Kovar. Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family , 2010, Sarcoma.
[8] C. Antonescu,et al. Extraskeletal myxoid chondrosarcoma , 2008, Cancer.
[9] Jungho Kim,et al. The hTAFII68‐TEC fusion protein functions as a strong transcriptional activator , 2008, International journal of cancer.
[10] M. Pierotti,et al. p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[11] F. Mertens,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone , 2002 .
[12] Y. Labelle,et al. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator , 1999, Oncogene.
[13] M. Ladanyi,et al. Skeletal and extraskeletal myxoid chondrosarcoma , 1998, Cancer.
[14] A. Scarpa,et al. Pathology and Genetics , 2010 .
[15] A. Tanigami,et al. Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins. , 1996, Genomics.
[16] R. Benjamin,et al. Extraskeletal Myxoid Chondrosarcoma Long‐Term Experience with Chemotherapy , 1995, American journal of clinical oncology.
[17] S. Hinrichs,et al. Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22. , 1985, Cancer genetics and cytogenetics.